Cardlytics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardlytics, Inc. on June 23, 2025. The filing discloses amendments to the employment and severance agreements of Amit Gupta, the Company's Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation adjustments.
Material Changes
The Company amended Mr. Gupta's existing offer letter and severance agreement on June 23, 2025. Key changes include:
- Equity Grant Adjustment: The "Second Tranche Awards" were amended to grant 1,000,000 Restricted Stock Units (RSUs) and 200,000 Performance Stock Units (PSUs) on the Grant Date.
- Vesting Schedule: The 2025 RSUs vest over two years (50% at one year, remainder quarterly). The 2025 PSUs vest based on share price targets over a three-year period starting April 1, 2025, with no vesting prior to April 1, 2026.
- Clawback Provision: If Mr. Gupta terminates employment before August 16, 2025, he must repay the pre-tax value of any vested 2025 RSUs.
- Future Grant Commitment: The Company agreed to grant additional RSUs and/or PSUs with a value of $5,000,000 (capped at 1,200,000 shares) on or before May 31, 2026, subject to Board approval.
- Severance Enhancement: In the event of termination without Cause or resignation for Good Reason, Mr. Gupta is entitled to 18 months of base salary and 18 months of medical benefits. Additionally, a Change in Control within specific windows triggers immediate full vesting of all unvested equity.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or general risk factors. The primary contingency noted is the repayment obligation for the 2025 RSUs if employment ends prior to August 16, 2025. The full text of the amended agreements will be filed as exhibits to the Form 10-Q for the quarter ending June 30, 2025.
Investor Verification Checklist
- Verify the exact share price used to calculate the $5,000,000 value for the 2026 equity grant commitment.
- Review the specific performance metrics for the 2025 PSUs once disclosed in the upcoming Form 10-Q.
- Confirm the total number of shares authorized under the 2025 Equity Incentive Plan to assess dilution impact.
- Monitor the Form 10-Q for the quarter ending June 30, 2025, for the full text of the amended agreements.